Q1 FY2021 · Press release
Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting · June 15, 2021 · 3 pages
Read Scholar Rock Holding Corporation's results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional